Comparison of patients with hyperparathyroidism and normocalcaemic hyperparathyroidism with regard to bone metabolism

• Conditions: M81.0; E21.0; Postmenopausal osteoporosis; Primary hyperparathyroidism

• Registration Number: DRKS00022216
• Lead Sponsor: niv. Klinik für NuklearmedizinParacelsus Medizinische Universitätsklinik Salzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Elevated parathyroid hormone in primary hyperparathyroidism

Exclusion Criteria

Parathyroid hormone in the normal range (<65), secondary or tertiary hyperparathyroidism

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differences in bone metabolism concerning T scores and TBS between normo- and hypercalcemic patients with PHPT

Secondary Outcome Measures

Name	Time	Method
Furthermore, differences in PET CT uptake in the patient groups will be investigated.